Caris Life Sciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Caris Life Sciences schedules its 2026 Annual Meeting of Shareholders for June 4, 2026, to elect ten directors and ratify Deloitte & Touche LLP as its independent auditor.